SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001158957-08-000178
Filing Date
2008-06-17
Accepted
2008-06-17 15:22:19
Documents
1
Period of Report
2008-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A f8k061708.htm 8-K/A 14607
  Complete submission text file 0001158957-08-000178.txt   16267
Mailing Address 933 MAMARONECK AVENUE SUITE 103 MAMARONECK NY 10543
Business Address 933 MAMARONECK AVENUE SUITE 103 MAMARONECK NY 10543 914-714-0567
NAREK PHARMACEUTICALS (Filer) CIK: 0001363584 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-52022 | Film No.: 08903059
SIC: 6770 Blank Checks
Assistant Director All